
IRIDEX (IRIX) Earnings Dates & Reports
IRIDEX (IRIX) Most Recent Earnings
Report DateNov 12, 2024
Period EndingQ3 2024
Est. EPS-$0.09
Actual EPS-$0.12
EarningsMiss
IRIDEX (IRIX) Earnings
View the latest IRIDEX (IRIX) earnings report, listen to the earnings call, and analyze historical earnings performance with AI-powered insights.
Start investing in IRIDEX (IRIX)
Order type
Buy in
Order amount
Est. shares
0 shares
IRIDEX (IRIX) Earnings per Share (EPS) History
Signup for full accessBrowse free
IRIDEX (IRIX) Latest Earnings
The value each IRIX share was expected to gain vs. the value each share gained.
IRIDEX (IRIX) reported its most recent earnings on Nov 12, 2024 for Q3 2024, posting earnings per share (EPS) of -$0.12. This exceeded analysts' expectations of -$0.09 by 33.33%, marking a Miss.
For comparison, IRIDEX reported EPS of -$0.11 in the same quarter last year.
The company is expected to announce its next earnings report on 08/07/2025, with analysts projecting an EPS of $0.
IRIDEX (IRIX) Earnings History
IRIDEX (IRIX) Earnings Related Price Changes
Earnings announcements may impact a stock’s price. This table highlights the IRIDEX’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.
Report date | Price 1D before | Price 1D after | Change |
---|---|---|---|
May 13, 2025 | — | — | — |
Mar 27, 2025 | — | — | — |
Nov 12, 2024 | — | — | — |
Aug 8, 2024 | — | — | — |
IRIDEX (IRIX) Earnings FAQs
IRIDEX (IRIX) last reported earnings on Nov 12, 2024 for Q3 2024, posting an EPS of -$0.12, which Miss the estimate of -$0.09 by 33.33%.
For Q3 2024, IRIDEX (IRIX) reported an EPS of -$0.12, missing analysts' estimate of -$0.09 by 33.33%.
For Q3 2024, IRIDEX (IRIX) Miss expectations with an actual EPS of -$0.12 vs. an estimated EPS of -$0.09.
Following the last earnings report on Nov 12, 2024, IRIDEX (IRIX)'s stock price moved — from — to —.
The next IRIDEX (IRIX) earnings call is scheduled for Aug. 7, 2025, where executives will discuss financial results and outlook.